Developing bioelectronic neuromodulation technologies to enhance cerebral waste clearance by modulating cerebrovascular dynamics and glymphatic system function.
Developing minimally invasive implantable bioelectronic fiber systems for targeted neuromodulation therapies and integrated neural interfacing in clinical and research contexts.
Developing biological foundation models and clinical research platforms to understand, detect, and prevent neurological disease through AI-driven neuroscience.
Developing thin-film implantable electrodes to enable high-precision neural recording, stimulation, and ablation in neurosurgical and neurological care.
Developing a minimally invasive, needle-delivered neuromodulation electrode platform to expand access to peripheral nerve stimulation for chronic pain treatment.
Developing functional ultrasound neuroimaging systems to enable high-resolution, real-time imaging of brain activity in research and clinical settings.
Developing a wearable EEG and digital biomarker platform to enable remote, objective measurement of brain function in clinical trials and neuroscience research.
Developing a non-invasive focused ultrasound platform to precisely open the blood–brain barrier and enable targeted drug delivery and brain diagnostics.
Developing assistive communication technologies that enable individuals with severe physical disabilities to interact with computers and speech-generating devices.
Developing a non-invasive infrared-based brain monitoring system to provide real-time cerebral perfusion, autoregulation, and intracranial pressure insights in critical care.
Developing a software-driven computer-brain interface platform that augments neuromodulation implants to enable communication and therapy personalization.
Developing non-invasive EEG-based diagnostic devices to rapidly assess traumatic brain injury and support clinical decision-making at the point of care.
Developing non-invasive brain-computer interface wearables for cognitive training, education, and assistive control using EEG-based neural signal decoding.
Providing a software-based cognitive assessment platform for rapid screening, monitoring, and diagnosis support across neurological and mental health conditions.
Developing connected medical devices and digital health software for ambulatory EEG acquisition, remote diagnostics, and continuous monitoring in neurology and related conditions.
Developing an implantable universal neural interface that enables intuitive two-way communication between the nervous system and external devices to restore movement and sensation.
Developing a hardware-agnostic brain-computer interface platform that decodes neural activity to deliver real-time cognitive and intention metrics via developer APIs and SDKs.
Providing a digital multimodal NeuroMarker platform to objectively assess and monitor cognitive function and detect early signs of neurodegenerative decline.
Developing a portable transcranial magnetic stimulation system to expand access to clinically validated neuromodulation treatments for mental health disorders.
Delivering wearable, high-density fNIRS systems (LUMO & NTS) for 3D brain imaging in infants and adults across research and clinical settings globally.
Providing a portable tDCS-based neuromodulation system for depression and chronic pain, enabling remote clinician management and scalable home treatment.
Providing Starstim and Enobio devices for wireless EEG monitoring and non-invasive brain stimulation, applied in research, clinical trials, and therapy.
Offering affordable wireless EEG-based BCI tools, including Explorer, Emotions, and MindLace, for research, neurofeedback, and accessibility applications.
Developing a non-invasive, AI-powered brain-computer interface (BCI) headset and proprietary neural-decoding platform to enable individuals with paralysis to control wheelchairs.
Developing Cerebro, a minimally invasive endovascular brain access platform that enables treatment of neurological disorders without drilling through the skull.